<DOC>
	<DOCNO>NCT00396656</DOCNO>
	<brief_summary>This study evaluate effect valsartan small vessel blood flow patient mild-to-moderate hypertension direct comparison atenolol hydrochlorothiazide .</brief_summary>
	<brief_title>Safety Efficacy Valsartan v Atenolol Hydrochlorothiazide Combination Blood Flow Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Caucasian ; male female outpatient age 4065 year age , inclusive . At Visit 2 patient must mean sit diastolic blood pressure ( msSBP ) â‰¥ 90 mmHg &lt; 110 mmHg . If single read arterial hypertension msSBP &gt; 180 mmHg msDBP &gt; 110 mmHg visit randomization . Inability discontinue prior antihypertensive medication safely period 2 week prior randomization . Known history hypotensive symptom orthostatic hypotension . Concomitant use statins statin intake four week prior Visit 1 . Known KeithWagener grade III IV hypertensive retinopathy . A history heart failure ( NYHA IIIV ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>hypertension</keyword>
	<keyword>valsartan</keyword>
	<keyword>atenolol</keyword>
	<keyword>hydrochlorothiazide</keyword>
	<keyword>microcirculation</keyword>
	<keyword>arterial compliance</keyword>
	<keyword>pulse wave analysis</keyword>
</DOC>